News

In 2017, precisely on April 10, 2017, NADFC held a Workshop / Improvement of Pharmacovigilance Competence to Healthcare Professionals at Udayana University Hospital, Denpasar. Besides the healthcare professionals at Udayana University Hospital, the Acting Head of the Provincial Office of NADFC in Denpasar, Dra. Luh Putu Witariati, Apt also attended this pharmacovigilance workshop.

This workshop was held in order to increase the competence and awarenees of healthcare professionals regarding pharmacovigilance so that the workshop can be a guide in monitoring and reporting of drug side effects to NADFC.

This event was officially opened by dr. Made Ayu Haryati, MARS as Head of Medical Services of Udayana University Hospital. The presentation of "Pharmacovigilance and patient safety" was delivered by Dr. Jarir At Thobari, MD, MSc., PhD as the keynote speaker from the Faculty of Medicine, Gadjah Mada University (UGM). The subsequent presentation was delivered by the Head of Sub-Directorate of Surveilance and Risk Analysis of Therapeutic Products and Household Medical Supplies, Siti Asfijah A, S.Si., Apt., MMedSc, on "Pharmacovigilance Program in Indonesia." The closing speech was delivered by I.B.N. Maharjana, S.Farm., M.Farm-Klim, Apt on "Monitoring of Drug Side Effects (ESO) in Udayana University Hospital and Constraints Faced ".

The participants were very enthusiastic about the workshop, in addition to acquiring new knowledge about the introduction of pharmacovigilance, the hospital also knew how the monitoring, handling and reporting of Adverse Drug Reaction took place at Udayana University Hospital. In the closing, Siti Asfijah A, S.Si., Apt., MMedSc and dr. Made Ayu Haryati, MARS expressed hope that this workshop can be a boost in the implementation of pharmacovigilance at Udayana University Hospital to achieve the goal of patient safety. (mda)

In 2017, precisely on April 10, 2017, NADFC held a Workshop / Improvement of Pharmacovigilance Competence to Healthcare Professionals at Udayana University Hospital, Denpasar. Besides the healthcare professionals at Udayana University Hospital, the Acting Head of the Provincial Office of NADFC in Denpasar, Dra. Luh Putu Witariati, Apt also attended this pharmacovigilance workshop.

This workshop was held in order to increase the competence and awarenees of healthcare professionals regarding pharmacovigilance so that the workshop can be a guide in monitoring and reporting of drug side effects to NADFC.

This event was officially opened by dr. Made Ayu Haryati, MARS as Head of Medical Services of Udayana University Hospital. The presentation of "Pharmacovigilance and patient safety" was delivered by Dr. Jarir At Thobari, MD, MSc., PhD as the keynote speaker from the Faculty of Medicine, Gadjah Mada University (UGM). The subsequent presentation was delivered by the Head of Sub-Directorate of Surveilance and Risk Analysis of Therapeutic Products and Household Medical Supplies, Siti Asfijah A, S.Si., Apt., MMedSc, on "Pharmacovigilance Program in Indonesia." The closing speech was delivered by I.B.N. Maharjana, S.Farm., M.Farm-Klim, Apt on "Monitoring of Drug Side Effects (ESO) in Udayana University Hospital and Constraints Faced ".

The participants were very enthusiastic about the workshop, in addition to acquiring new knowledge about the introduction of pharmacovigilance, the hospital also knew how the monitoring, handling and reporting of Adverse Drug Reaction took place at Udayana University Hospital. In the closing, Siti Asfijah A, S.Si., Apt., MMedSc and dr. Made Ayu Haryati, MARS expressed hope that this workshop can be a boost in the implementation of pharmacovigilance at Udayana University Hospital to achieve the goal of patient safety. (mda)

How do you think the content and appearance of this website?




logo dsras Email Rapid Alert System

Selamat email anda telah berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia.

 

logo dsras Email Rapid Alert System

Anda ingin berhenti berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia?